The development of generic versions of innovator medicines is a global public health need.
In the U.S. and around the world, quality standards developed by the U.S. Pharmacopeia (USP) support the availability of safe, quality medicines, regulatory efficiencies, and a strong global medicine supply chain.
Global health advocate Mirfin Moundu talks about the dangers of poor quality medicines and how they are a threat to many Africans in treating infectious diseases and non-communicable diseases.
In Nigeria, mothers frequently deliver their babies at home—only 36 percent deliver at health care facilities. Giving birth without the assistance of trained healthcare providers leaves babies vulnerable to infections, and some can be fatal.
In conversations about the role of quality standards in public health, you might come across the words “compendia” and “compendial.” At USP, terms like “compendial approaches,” “compendial standards,” and “compendial tools” are part of our everyday vocabulary.
The opioid crisis in the U.S. seems to be part of nearly every news broadcast and news site today. And based on the number of people affected by this crisis, serious conversations about how to help are more important than ever.
A healthier world needs a strong foundation—one that establishes quality, sets the bar for scientific rigor and technological progress, between industry, nonprofits, government and academia.
Show 11 More